Jeppe Bennekou Schroll serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, based at Blegdamsvej 3, 2200 Copenhagen N, Denmark. His research expertise spans: Gynecology and Obstetrics Cervical Cancer Screening methodologies HPV Vaccination impact assessment Women's Urological Health Elderly Women's Gynecological Care Population-based Medical Research Dr. Schroll's 2025 publications demonstrate a concentrated focus on evidence-based gynecological interventions using Danish population data. His work bridges clinical practice and public health through cohort studies on HPV vaccination efficacy, surgical outcomes in elderly patients, and innovative non-surgical treatments for urinary incontinence. The research consistently employs robust methodologies including population registries and randomized controlled trials, with significant media coverage across 14 news outlets and social platforms.
Alessandra Meddis serves as an Assistant Professor in the Section of Biostatistics within the Department of Public Health at the University of Copenhagen's Faculty of Health and Medical Sciences. Her academic work centers on developing and applying advanced statistical methodologies for longitudinal and time-to-event data analysis, with significant contributions to public health research in Denmark and internationally. Her institutional affiliation is clearly established through university contact details and departmental listings. Her primary research interests include correlated survival data analysis, competing risk modeling, informative cluster size methodology, causal inference techniques for observational studies, and environmental epidemiology applications. Dr. Meddis has developed specialized expertise in handling complex survival data structures while maintaining focus on real-world public health problems, particularly in HIV comorbidity patterns, environmental exposure effects, and pandemic-related mortality analyses. Her methodological innovations directly address challenges in clustered and censored data common across medical research domains. Analysis of Dr. Meddis's recent publication record reveals a consistent trajectory of high-impact interdisciplinary research spanning clinical medicine, epidemiology, and statistical methodology. Her work appears in leading journals across biostatistics, infectious diseases, and public health, demonstrating strong collaborative networks with clinical researchers and epidemiologists. Key thematic areas include HIV treatment outcomes, environmental health exposures, and critical care applications during the pandemic, with recent methodological papers advancing survival analysis techniques for complex data structures. Scientific Awards: No scientific awards were specified in the available institutional profile. Advising and Grants: The institutional profile does not provide details regarding graduate student supervision or specific research grant funding. Her collaborative publications suggest involvement in multi-investigator projects including the COCOMO HIV cohort study and pandemic-related research initiatives. Labs and Teams: Dr. Meddis is affiliated with the Section of Biostatistics within the Department of Public Health, though specific laboratory facilities or dedicated research teams are not described in the source material. Her extensive co-authorship patterns indicate active participation in multiple research consortia across medical specialties.
Annette Juul Vangsted serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her clinical specialization is in Internal Medicine with a focus on Hematology, specifically multiple myeloma. Based at Blegdamsvej 9 in Copenhagen, she maintains an active research profile with 67 documented research outputs and extensive collaborations across Nordic countries and internationally. Dr. Vangsted's research primarily centers on multiple myeloma, with particular emphasis on genetic predisposition, treatment outcomes, epidemiological patterns, and bone disease management. Her work bridges clinical practice with genetic research, examining how genetic variants influence disease risk and progression. She investigates geographical variations in myeloma incidence and outcomes, as well as novel treatment approaches for elderly patients and those with specific genetic profiles. Analysis of her recent publications reveals a clear focus on multiple myeloma across several dimensions: genetic susceptibility (including large genome-wide association studies), treatment efficacy (particularly regarding bone disease management), epidemiological patterns across Nordic countries, and specialized care for elderly populations. Her collaborative approach is evident through numerous multi-center studies involving Nordic Myeloma Study Group and international research teams. Dr. Vangsted actively participates in clinical research through the Nordic Myeloma Study Group, contributing to registry studies and clinical trials that inform treatment guidelines for multiple myeloma. Her work has significant implications for understanding disease mechanisms and improving patient outcomes, particularly in the areas of genetic risk assessment and personalized treatment approaches. She maintains strong research collaborations across Denmark, Sweden, and international institutions, with particular focus on hematological malignancies. Her laboratory and clinical research team works within the Department of Clinical Medicine's hematology division, focusing on translational research that directly impacts clinical practice for myeloma patients.
Maria Timofeeva is an Associate Professor in the Epidemiology, Biostatistics and Biodemography (EBB) department at the University of Southern Denmark (SDU), with additional affiliation at the Danish Institute for Advanced Study (DIAS). She holds an Honorary Fellow position at the University of Edinburgh since December 2019. Her research focuses on cancer prevention and prediction, particularly studying the effects of environmental and genetic factors on cancer risk and progression. Dr. Timofeeva earned her Dr.sc.hum in Epidemiology from Heidelberg University (2005-2009), with a dissertation on genetic polymorphisms as risk factors for early onset lung cancer. Prior to her current position, she worked as a Statistical Geneticist at the University of Edinburgh (2013-2019) and as a Postdoctoral Fellow at the International Agency for Research on Cancer (2009-2013). Her research interests center around understanding the genetics of cancer risk through multi-omic analysis. She leads several significant projects, including the Interdisciplinary Project on Adherence to Colorectal Cancer Screening, meta-analysis of factors associated with false-positive and false-negative FOBT results (registered in PROSPERO ID: CRD42022315767), and the COlorectal Cancer screening Among RElatives (CoCARE) twin-family study in Denmark. Her methodological expertise spans observational epidemiological studies (case-control, population-based cohort studies, twin studies), meta-analysis, umbrella reviews, and multi-omics data analysis. Analysis of her recent publications reveals a strong focus on colorectal cancer genetics, with particular emphasis on genome-wide association studies, Mendelian randomization approaches, and trans-ancestry analyses. Her work frequently leverages large datasets including the UK Biobank and international consortia, with applications in cancer risk prediction and understanding gene-environment interactions. Dr. Timofeeva has an extensive publication record with 73 publications listed in her profile. Her research has been cited across multiple platforms, with mentions in news outlets, social media, and academic readership platforms like Mendeley. She is actively involved in academic service, serving as a peer reviewer for journals including BMC Cancer and Scientific Reports, and participating in conferences such as the 26th Nordic Congress of Gerontology. She also serves on evaluation committees, including with the World Cancer Research Fund International (April-May 2024). Her teaching activities include courses on evidence-based drug utilization and biostatistics, as well as supervision of research projects on gene expression in twins. Dr. Timofeeva has engaged with the public through media contributions, including an interview titled 'Jeg vil forstå, hvorfor vi får kræft' (November 15, 2021), where she discussed understanding why we get cancer.
Søren Lundbye-Christensen is an Associate Professor and Biostatistician affiliated with the Clinical Institute at the Faculty of Health Sciences, Aalborg University, and Aalborg University Hospital in Denmark. He specializes in biostatistical support for medical research, with a strong emphasis on cardiovascular and epidemiological studies. His research interests include biostatistics, survival analysis, cohort studies, clinical epidemiology, and statistical modeling in public health. He has contributed to a wide array of healthcare research, particularly in cardiovascular diseases, cancer, maternal health, and infectious diseases. His methodological expertise spans time-to-event analysis, registry-based research, and interval-censored data modeling. The recent publications highlight a strong trend in applying advanced statistical methods to large-scale clinical and population-based datasets. His work often involves collaboration with medical researchers to derive prognostic models, validate clinical databases, and assess public health outcomes. Key themes include cardiovascular risk, fertility, cancer biomarkers, and implementation of medical training programs. Scientific Contributions and Recognition: Published over 320 research articles and datasets. Active contributor to methodological advancements in biostatistics. Regular peer reviewer, including for journals like the R Journal. Public engagement through media appearances on statistics and health. Academic Advising and Grants: Søren has supervised 31 student theses, formally serving as PhD supervisor for 14 theses and as a biostatistical advisor for 19 others, primarily in mathematics and statistics. He has participated in numerous research projects funded through institutional and national grants, including studies on seasonal disease trends, postoperative complications, and metabolic disease prediction. His work often involves interdisciplinary collaboration across medicine, public health, and data science. Labs and Research Teams: He is embedded in collaborative research networks at Aalborg University Hospital and Aalborg University, contributing statistical expertise to clinical research groups. He is involved in projects utilizing Danish national health registries and has contributed to the development and validation of clinical databases. His work supports both hypothesis-driven medical research and methodological innovation in biostatistics.
Kristine Bihrmann serves as a Senior Researcher at the National Institute of Public Health, University of Southern Denmark. Her primary research area is geographical and register-based epidemiology, utilizing Denmark's extensive national health registries to investigate spatial patterns of disease occurrence and healthcare utilization. She has co-authored numerous studies on topics including cervical cancer screening, acute myocardial infarction, and social inequities in chiropractic care. Bihrmann's research interests center on epidemiology with a strong emphasis on spatial analysis and register-based methods. Key areas include chronic disease epidemiology (particularly cardiovascular diseases and cancer), social epidemiology examining socioeconomic disparities, and public health interventions. Her work often explores the interplay between geography, healthcare access, and health outcomes in the Danish population. Her recent publications demonstrate a consistent focus on spatial epidemiology and health services research. She frequently employs register-based cohort and cross-sectional designs to investigate how geographic factors influence healthcare utilization and disease outcomes. Notable themes include the impact of travel distance on preventive care and acute conditions, as well as social determinants of health across various medical conditions. No scientific awards were mentioned in the available information. Information regarding academic advising and research grants was not provided in the source material. Bihrmann conducts her research within the National Institute of Public Health, leveraging Denmark's unique health registries for population-based epidemiological studies. Her work contributes to understanding regional health disparities and informing public health policy in Denmark.
Zorana Jovanovic Andersen is an Associate Professor at the University of Copenhagen, Department of Public Health, Section of Environmental Health, specializing in Environmental and Occupational Epidemiology. Her research focuses on health impacts of air pollution , noise exposure , and lifestyle factors across large cohorts including the Danish Nurse Cohort and Diet, Health, and Cancer cohort. Primary research areas: Environmental Epidemiology, Breast Cancer Risk, Air Pollution, Noise Studies, Physical Activity Interactions Key projects: Hyperion (road traffic noise), ELAPSE (low-level air pollution), TAPAS (climate-transportation health risks) Research Themes She investigates long-term exposure to air pollution and noise in relation to breast cancer , diabetes , cardiovascular disease , and brain cancer , while exploring how factors like physical activity modify these risks. Recent work includes dementia and COVID-19 mortality analyses. Scientific Contributions Her 15 most recent publications address: 1) Air pollution disparities in Europe 2) Dementia-air pollution links 3) Stroke-noise interactions 4) Airport ultrafine particle exposure 5) Asthma-COPD overlap 6) Breast cancer-mammographic density relationships. Major Grants Danish Working Environment Research Fund (1.79M DKK, 2017) Danish Heart Association (433K DKK, 2016) Danish Council for Independent Research (1.93M DKK, 2015) Teaching & Leadership Course Leader for Data Processing in Health Care and Public Health Informatics at UCPH since 2011. Organized Danish Health Registries seminars and served on scientific committees for environmental conferences.
Anton Pottegård is a Professor at the University of Southern Denmark and Head of Research at Hospital Pharmacy Funen (Odense University Hospital). His work combines registry-based pharmacoepidemiological research with clinical investigations into deprescribing practices. Affiliation: University of Southern Denmark Secondary Role: Head of Research, Odense University Hospital Research interests focus on pharmacoepidemiology and clinical pharmacy , particularly real-world drug safety and deprescribing in geriatric care. His methodology emphasizes Danish healthcare registries for longitudinal analyses of medication patterns and adverse outcomes. Notable contributions include epidemiological analyses of opioid utilization , migraine treatments , and GLP-1 receptor agonists . He has developed frameworks for pharmacoepidemiological methodology and drug safety surveillance , co-authored over 300 publications, and led the REDO project on reducing opioid use in osteoarthritis. Additional activities include media commentary on TBE vaccination and tick-borne diseases , with 613 press/media appearances reflecting public health engagement. Supervised work includes 7 doctoral candidates and cross-national collaborations.
Henrik Møller is a Professor at the Danish Center for Health Services Research , part of the Faculty of Health Sciences at Aalborg University . His work focuses on cancer epidemiology , clinical quality registries , and health services research , particularly examining prostate cancer , lung cancer , and colorectal cancer through nationwide cohort studies. Key research areas: Cancer care quality, pandemic impacts on diagnosis/treatment, socioeconomic disparities Active collaborations in Denmark and England Contributor to national and international cancer registries Recent publications analyze CT imaging trends in lung cancer detection, chemotherapy disparities in pancreatic cancer, and genetic biomarkers in gliomas. His team has released multiple datasets on figshare platforms. As a leader in health services research, Møller's work informs healthcare policy improvements through evidence-based quality indicators and development targets.
Karl Bang Christensen is a Professor at the Department of Public Health, Section of Biostatistics, within the Faculty of Health and Medical Sciences at the University of Copenhagen. His primary research areas include Biostatistics, Item Response Theory (IRT) models, scale validation, patient-reported outcomes (PRO), and multi-state models for sickness absence analysis. Research interests: Rasch models and latent variable models for health outcomes Statistical methods for evaluating PRO instruments Exercise interventions in cancer rehabilitation Multi-state modeling of administrative register data (sickness absence, unemployment, disability pension) Article trends: His publications focus on Rasch models, IRT, survival analysis, clinical trials, and health education. Recent work addresses preventive health interventions in dermatology, while earlier studies emphasize cognitive dysfunction, migraine treatment, and social determinants of sickness absence. Teaching: He teaches statistics at the Master of Health Sciences and PhD levels.
Mette Nyegaard is a Professor in the Department of Health Science and Technology at Aalborg University, within The Faculty of Medicine. Her research focuses on genetics and genomics, with over 25 years of expertise linking genetic variation to phenotypes in both rare and common complex diseases. She has a strong interest in gender medicine and women’s reproductive health, particularly leading Denmark’s contribution to the largest genome-wide association analysis of endometriosis. Nyegaard has held external positions, including Associate Professor roles at Aarhus University and Senior Scientist at Aarhus University Hospital. Education: PhD in Human Genetics, University of Southern Denmark (2003) MSc in Chemistry-Biotechnology, Aarhus University (1997) Research Interests: Nyegaard’s work spans genetics, genomics, GWAS, endometriosis, coronary artery disease, and personalized medicine. Her research emphasizes translating genetic insights into clinical applications, such as polygenic risk scores and biomarker development. She collaborates internationally, with projects addressing calmodulinopathies, cardiovascular genetics, and reproductive health. Projects & Grants: Lead PI on projects like 'Understanding the Genetic Architecture of Common Complex Diseases' and 'FEMaLe: Finding Endometriosis Using Machine Learning.' Co-Investigator in studies like 'The Deadly, the Deleterious, and the Dangerous – Decoding the Differential Pathogenicity among CALM1, CALM2, and CALM3.' Labs/Teams: Nyegaard’s work is part of interdisciplinary teams at Aalborg University and collaborating institutions, focusing on genomic medicine, endometriosis, and cardiovascular genomics. She contributes to initiatives like Neuroboost and the International Calmodulinopathy Registry.
Rasmus Nielsen is a Professor at the University of Copenhagen, specifically affiliated with the Globe Institute and the Section for Geogenetics. His research spans evolutionary genetics, population genetics, and computational genomics with a focus on both human and non-human species. He maintains an active research profile with numerous high-impact publications in leading scientific journals. Professor Nielsen's research interests center around evolutionary and population genetics, with particular expertise in ancient DNA analysis, statistical methods for genomic data, and phylogenetics. His work bridges computational biology with empirical data from diverse species, including humans, plants, and other organisms. He has made significant contributions to understanding human evolutionary history, population structure, and the genetic basis of adaptation. His research also extends to medical genomics, particularly in understanding the genetic architecture of complex traits and diseases. His recent publications demonstrate a strong focus on methodological development in genomic analysis, with papers appearing in top-tier journals like Nature , Science , and Nature Reviews Genetics . His work shows consistent engagement with both theoretical and applied aspects of genetics, spanning human evolutionary history, medical genomics, and plant evolutionary biology. The research output reveals a collaborative approach, with frequent co-authorship across multiple institutions and disciplines. As a Professor at the University of Copenhagen's Globe Institute, Nielsen leads research within the Section for Geogenetics, which focuses on evolutionary and population genetics using cutting-edge genomic approaches. The section maintains strong connections with both computational and empirical research groups, facilitating interdisciplinary work that spans from methodological development to application in diverse biological contexts.
Lasse Hjort Kyneb Jakobsen is an Associate Professor at the Department of Mathematical Sciences, Faculty of Engineering and Science, Aalborg University. His academic work bridges statistical methodology with clinical applications in hematology and oncology. Primary Affiliation : Aalborg University (Department of Mathematical Sciences) Research Focus : Survival analysis, competing risks modeling, and clinical epidemiology. Recent work includes methodological advancements in temporal survival trend analysis and population-based studies of lymphoma outcomes. Key contributions address chemotherapy-induced peripheral neuropathy (NOVIT study) and SARS-CoV-2 severity in immunocompromised patients. Scientific Honors : Kræftens Bekæmpelse Research Honor (2022) for cancer epidemiology contributions Collaborations span hematology-oncology departments, with datasets on SARS-CoV-2 outcomes and prognostic modeling for elderly populations. Co-authorship network reveals strong ties to clinical lymphoma research (Diffuse Large B-Cell Lymphoma, 100% fingerprint overlap).
Carsten Dahl Mørch is an Associate Professor at the Department of Health Science and Technology, Faculty of Medicine, Aalborg University. He leads the Cutaneous Pain Research Laboratory and is affiliated with the Center for Sensory-Motor Interaction and the Translational Pain Neuroscience and Precision Health Center. His research focuses on pain mechanisms, diabetic neuropathy, peripheral nerve function, and neuroplasticity. He holds a Ph.D. in Biophysics and an M.Sc. in Biophysics. Education: Ph.D. in Biophysics (2006) M.Sc. in Biophysics (2002) Research Interests: Diagnosis of small fiber neuropathy Experimental methods for studying hyperalgesia Digitalization of human neuroscience Pain perception complexity Neuropathic pain in diabetes Key Projects: Diabetic Peripheral Neuropathy: Early detection and severity grading (2018–present) Computational modeling of peripheral nerves (2017–present) Assessment of oxaliplatin-induced peripheral neuropathy (2014–present) Labs/Teams: Cutaneous Pain Research Laboratory Center for Neuroplasticity and Pain
Claus Aalykke is a Clinical Lecturer at the Department of Clinical Research, University of Southern Denmark, with affiliations to KI and OUH. He works within the Research unit of Medicine in Svendborg and focuses on gastroenterology and clinical medicine. Dr. Aalykke's research primarily centers on inflammatory bowel diseases, with particular emphasis on: Diagnostic approaches and biomarker development for inflammatory bowel disease Clinical management of inflammatory bowel disease Colorectal cancer surveillance in IBD patients Pharmacological treatments including biological therapies Sex and gender differences in inflammatory bowel disease outcomes Upper gastrointestinal bleeding and NSAID-related complications His recent research output demonstrates a strong focus on improving diagnostic accuracy and personalized treatment approaches for inflammatory bowel disease patients. He has been actively involved in large cohort studies including the Nordic inception cohort study (NORDTREAT) and has contributed to developing clinical guidelines for colonoscopic surveillance in IBD patients. His work spans both clinical practice guidelines and innovative research on biomarkers and treatment outcomes. Dr. Aalykke has published extensively in high-impact gastroenterology journals including The Lancet Gastroenterology & Hepatology and Scandinavian Journal of Gastroenterology, with multiple publications in 2024 indicating active current research. He has supervised at least one research project as indicated by the 'Supervised Work (1)' notation in his profile and collaborates extensively with researchers across Nordic countries and internationally.
